| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Quest, one of the nation’s top commercial laboratory companies, has dialed up testing as the pandemic increasingly infects American citizens. Quest’s journey to helping aid in the COVID-19 pandemic sweeping across the United States began seven weeks ago when the Food and Drug Administration authorized the commercial lab company to move forward with developing and running its own test, under a temporary emergency authorization.
Quest Diagnostics, through its “Peace of Mind” program, is taking extra measures to ensure individuals who are the most vulnerable to adverse COVID-19 outcomes have special access to the company’s 2,250 patient service centers across the United States. Through this new program, individuals who are 60 years or older – or have other conditions known to raise the risk of an unfavorable outcome from COVID-19 – will have special access to centers during the first hour of each day each center opens.
CEO Steve Rusckowski joins “Closing Bell” to discuss the company’s coronavirus testing efforts.
Quest Diagnostics received on Tuesday Emergency Use Authorization from the US Food and Drug Administration for its SARS-CoV-2 rRT PCR test. The issuance allows Quest to provide the test for individuals suspected by their healthcare providers of having COVID-19.
Massachusetts Governor Charlie Baker pledged Thursday morning that Massachusetts would soon see an “enormous increase” in testing for coronavirus as he acknowledged that the state’s capacity to screen people remained far below what was needed to blunt the local impact of the pandemic. Baker spoke to reporters after touring the private laboratory at Quest Diagnostics, which plans to rapidly ramp up its coronavirus testing. By next week, Quest hope to preform 2,000 to 3,000 tests a day at its facility in Marlborough, according to its chief executive officer, Steve Rusckowski, who joined Baker at the press conference